Abstract:Scale-up production technology of highly purified bacillomycin D was established to support the exploration for its agriculturally antibiotic activity. After isolation, purification and molecular identification, the bioactive compounds extracted from Bacillus amyloliquefaciens TYg 3-2 were identified as antibiotic lipopeptides bacillomycin D. The refined nature media and chemically defined available carbon and nitrogen sources, including yeast extract, peptone, glucose, and (NH4)2SO4, were combined and optimized using response surface method for high-yield complex medium of bacillomycin D. Using the optimized medium, the yield of bacillomycin D in 5 L bioreactor reached 990 mg/L. The productivity reached 20.62 mg/(L·h), which was much higher than the previously reported productivity of 10.23 mg/(L·h). Biomass-supernatant separation, acid precipitation, methanol extraction, Et2O precipitation, macroporous absorption resin column chromatography and silica gel column chromatography were conducted for efficient purification of bacillomycin D. And 94.72%purity was obtained when high-quality raw material was used. Preliminary exploration for antibiotic activity was conducted using the highly purified bacillomycin D sample. Inhibition tests in vitro demonstrated that bacillomycin D was the main effective substance against Drechslera turcica, Curvularia lunata, Ustilaginoidea virens and Alternaria longipes in vitro. And the result of pot test in vivo revealed that bacillomycin D was the promotor on biocontrol efficacy of homologous B. amyloliquefaciens TYg 3-2 biomass. Because the mixture of 500 mg/L bacillomycin D and 4 × 106 CFU/mL B. amyloliquefaciens TYg 3-2 biomass exhibited 95.3% biocontrol efficacy against Colletotrichum orbiculare in vivo, which was higher than those of bacillomycin D alone (78.4%) and Bacillus biomass alone (0). The potential value of bacillomycin D in the field of agricultural antibiotic was preliminarily explored. And scale-up production technology of highly purified lipopeptides played an important role in this exploration. Not only could it isolate and purify target lipopeptide from fermentation broth for this agricultural antibiotic research without the loss in producing bacteria (the spore of which was the feedstock of biocontrol agent), but also can it satisfy the requirement of toxicological tests of pesticide registration in China (sample with >85% purity in grams). As a result, this research was able to support the research and development of agriculturally antibiotic value in Bacillus lipopeptides.

A New Cyclic Lipopeptide Isolated from Bacillus Amyloliquefaciens HAB-2 and Safety Evaluation.

Isolation, Purification and Structure Determination of a Novel Antifungal Compound

Identification of a Novel Antifungal Strain and Its Biocontrol Effect on Plant Pathogenic Fungi

Antibacterial Activity of Bacillomycin D-like Compounds Isolated from Bacillus Amyloliquefaciens HAB-2 Against Burkholderia Pseudomallei

Safe Antifungal Lipopeptides Derived from Bacillus Marinus B-9987 Against Grey Mold Caused by Botrytis Cinerea

[Isolation, purification and antitumor activity of Bacillomycin D from Bacillus amyloliquefaciems Q-426]

Bacillus amyloliquefaciens YN201732 Produces Lipopeptides With Promising Biocontrol Activity Against Fungal Pathogen Erysiphe cichoracearum

Purification and Identification of Two Antifungal Cyclic Peptides Produced by Bacillus Amyloliquefaciens L-H15

Comparative Genomics Analysis Provides New Strategies For Bacteriostatic Ability Of Bacillus Velezensis Hab-2

A marine lipopeptides-producing Bacillus amyloliquefaciens HY2-1 with a broad-spectrum antifungal and antibacterial activity and its fermentation kinetics study

Bacillomycin D-like compounds isolated from Bacillus amyloliquefaciens HAB-2 are effective against Burkholderia pseudomallei

Antifungal Mechanism of Bacillomycin D from Bacillus Velezensis HN-2 Against Colletotrichum Gloeosporioides Penz.

Isolation and identification of lipopeptide antibiotics from Paenibacillus elgii B69 with inhibitory activity against methicillin-resistant Staphylococcus aureus

Mechanism of Antibacterial Activity of Bacillus Amyloliquefaciens C-1 Lipopeptide Toward Anaerobic Clostridium Difficile

Extraction and Characterization of Cyclic Lipopeptides with Antifungal and Antioxidant Activities from Bacillus Amyloliquefaciens

Fermentation and Purification Optimizations of Bacillomycin D , and Preliminary Exploration for Its Antibiotic Activity

Functions of lipopeptides bacillomycin D and fengycin in antagonism of Bacillus amyloliquefaciens C06 towards Monilinia fructicola.

Characterization of Novel Cyclic Lipopeptides Produced by Bacillus Sp. SY27F

Bacillus amyloliquefaciens strain 32a as a source of lipopeptides for biocontrol of Agrobacterium tumefaciens strains

Lipopeptides from Bacillus velezensis ZLP-101 and their mode of action against bean aphids Acyrthosiphon pisum Harris

Production of Bacillomycin- and Macrolactin-Type Antibiotics by Bacillus Amyloliquefaciens NJN-6 for Suppressing Soilborne Plant Pathogens.